We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others. Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.
PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference...
PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference...
PARSIPPANY, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, announced it will ring the Nasdaq Closing Bell today in recognition...
While 9 out of 10 people with diabetes are living with T2D, many of the automated insulin delivery solutions currently on the market were designed for people living with T1D.300-unit insulin...
PARSIPPANY, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that...
PARSIPPANY, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and...
PARSIPPANY, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.79 | -11.4743589744 | 15.6 | 15.64 | 13.05 | 383075 | 14.03578033 | CS |
4 | -0.24 | -1.70818505338 | 14.05 | 16.37 | 13.05 | 283142 | 14.786241 | CS |
12 | -1.66 | -10.7304460246 | 15.47 | 17.05 | 12.42 | 365857 | 14.83686824 | CS |
26 | -0.12 | -0.861450107681 | 13.93 | 17.33 | 11.46 | 373038 | 14.19032986 | CS |
52 | -2.21 | -13.7952559301 | 16.02 | 19.79 | 9.925 | 419209 | 14.69492516 | CS |
156 | -18.55 | -57.3238566131 | 32.36 | 36.64 | 9.925 | 623008 | 23.75183509 | CS |
260 | -18.55 | -57.3238566131 | 32.36 | 36.64 | 9.925 | 623008 | 23.75183509 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions